Enlivex Therapeutics Ltd. - Report Publication Announcement 2019

_________ false


	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	14/11/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-098022	Time of broadcast: 13:28 13:23:56

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on6-k

6k_isa.pdf

Link to filing on foreign stock exchange (optional): _________



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 29/10/2019
Address: Einstein 14 , NES-ZIONA 7403618 , ISRAEL Tel: 02-6708072 , Fax: 02-6708070
E-mail address: [email protected] Company site: www.enlivex.com

Previous names of reporting entity:

Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: Enlivex thetraputics R&D
Address: Nachal Dan 19 , Qiryat Uno 61580 Telephone: 054-4617610 Facsimile: - E-mail: [email protected] 2
ISRAEL

AI assistant